ES2112818T1 - Composicion farmaceutica que comprende lactobacillus plantarum y arginina. - Google Patents

Composicion farmaceutica que comprende lactobacillus plantarum y arginina.

Info

Publication number
ES2112818T1
ES2112818T1 ES96914505T ES96914505T ES2112818T1 ES 2112818 T1 ES2112818 T1 ES 2112818T1 ES 96914505 T ES96914505 T ES 96914505T ES 96914505 T ES96914505 T ES 96914505T ES 2112818 T1 ES2112818 T1 ES 2112818T1
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
lactobacillus plantarum
arginin
composition including
including lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES96914505T
Other languages
English (en)
Other versions
ES2112818T3 (es
Inventor
Diya Adawi
Bengt Jeppson
Goeran Molin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probi AB
Original Assignee
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi AB filed Critical Probi AB
Publication of ES2112818T1 publication Critical patent/ES2112818T1/es
Application granted granted Critical
Publication of ES2112818T3 publication Critical patent/ES2112818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA CEPA DE LACTOBACILLUS PLANTARUM QUE TIENE LA CAPACIDAD DE COLONIZAR LA MUCOSA INTESTINAL HUMANA IN VIVO, EN COMBINACION CON ARGININA Y UN VEHICULO FARMACEUTICAMENTE ACEPTABLE. LA COMPOSICION PUEDE UTILIZARSE PARA EL TRATAMIENTO CURATIVO Y/O PROFILACTICO DE LAS LESIONES HEPATICAS E INSUFICIENCIA HEPATICA Y TRANSLOCACION BACTERIANA ASOCIADA EN MAMIFEROS INCLUYENDO EL HOMBRE.
ES96914505T 1995-05-09 1996-05-08 Composicion farmaceutica que comprende lactobacillus plantarum y arginina. Expired - Lifetime ES2112818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501719A SE9501719D0 (sv) 1995-05-09 1995-05-09 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
ES2112818T1 true ES2112818T1 (es) 1998-04-16
ES2112818T3 ES2112818T3 (es) 2003-02-16

Family

ID=20398250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96914505T Expired - Lifetime ES2112818T3 (es) 1995-05-09 1996-05-08 Composicion farmaceutica que comprende lactobacillus plantarum y arginina.

Country Status (16)

Country Link
EP (1) EP0825869B1 (es)
JP (1) JP4058560B2 (es)
KR (1) KR19990008403A (es)
CN (1) CN1152678C (es)
AT (1) ATE221783T1 (es)
AU (1) AU704886B2 (es)
BR (1) BR9608284A (es)
CA (1) CA2220498A1 (es)
DE (2) DE69622855T2 (es)
EE (1) EE03597B1 (es)
ES (1) ES2112818T3 (es)
GR (1) GR980300028T1 (es)
NO (1) NO317668B1 (es)
PL (1) PL184603B1 (es)
SE (1) SE9501719D0 (es)
WO (1) WO1996035440A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
ATE348626T1 (de) 2000-03-24 2007-01-15 Nestle Sa Milchsäurebakterium zur prävention der bauchfellentzündung
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005094848A1 (ja) 2004-03-31 2005-10-13 Calpis Co., Ltd. 肝障害予防又は抑制剤及び肝障害予防又は抑制用機能性食品
KR100592717B1 (ko) * 2004-11-20 2006-06-26 주식회사 알엔에이 간 손상 보호 및 예방에 유용한 활성을 갖는 조성물
CN1322111C (zh) * 2004-12-17 2007-06-20 上海交大昂立股份有限公司 一种植物乳杆菌
CN100337653C (zh) * 2004-12-21 2007-09-19 上海交大昂立股份有限公司 一种含有植物乳杆菌的组合物
DK1931363T3 (en) * 2005-09-28 2016-02-22 Nordisk Rebalance As Treatment of IBD using both probiotic bacteria and fermented cereal as behandlingseffektorer
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
KR101075557B1 (ko) 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101075558B1 (ko) * 2008-12-03 2011-10-20 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
JP5823695B2 (ja) * 2008-12-03 2015-11-25 国立大学法人広島大学 肝機能障害予防剤
KR101255050B1 (ko) 2009-07-14 2013-04-16 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
WO2018195067A1 (en) 2017-04-17 2018-10-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
EP4444332A1 (en) * 2021-12-09 2024-10-16 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota

Also Published As

Publication number Publication date
BR9608284A (pt) 1999-06-08
CA2220498A1 (en) 1996-11-14
PL184603B1 (pl) 2002-11-29
AU5784696A (en) 1996-11-29
WO1996035440A1 (en) 1996-11-14
NO975136D0 (no) 1997-11-07
NO975136L (no) 1997-11-07
GR980300028T1 (en) 1998-04-30
EP0825869A1 (en) 1998-03-04
CN1190346A (zh) 1998-08-12
DE69622855T2 (de) 2003-04-10
DE825869T1 (de) 1998-07-16
NO317668B1 (no) 2004-11-29
EE9700269A (et) 1998-04-15
AU704886B2 (en) 1999-05-06
JPH11504936A (ja) 1999-05-11
ATE221783T1 (de) 2002-08-15
KR19990008403A (ko) 1999-01-25
CN1152678C (zh) 2004-06-09
JP4058560B2 (ja) 2008-03-12
ES2112818T3 (es) 2003-02-16
DE69622855D1 (de) 2002-09-12
EE03597B1 (et) 2002-02-15
EP0825869B1 (en) 2002-08-07
PL323320A1 (en) 1998-03-16
SE9501719D0 (sv) 1995-05-09

Similar Documents

Publication Publication Date Title
ES2112818T3 (es) Composicion farmaceutica que comprende lactobacillus plantarum y arginina.
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
ID30071A (id) Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental
HU9603251D0 (en) Lactobacillus strains of human origin, their compositions and uses thereof
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
MY120501A (en) Micro-encapsulated lactobacilli for medical applications
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
WO1998035658A3 (de) Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
MY114776A (en) Fluoxetine pharmaceutical formulations
ZA947894B (en) Compounds for medicinal use
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
IT1274733B (it) Ceppo del genere lactobacillus di origine umana e suoi usi
Garg Role of omeprazole in prevention and treatment of postendoscopic variceal sclerotherapy esophageal complications
MD20010055A (ro) Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale
AU1756299A (en) Use of putamen ovi
UA30011A (uk) Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань
UA31364A (uk) Спосіб лікування дисбактеріозу кишечнику у хворих на гострий пієлонефрит
MD20010076A (ro) Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei
UA10219A (uk) Спосіб лікування туберкульозу легень